Clinical Genitourinary Cancer

Clinical Genitourinary Cancer is a bi-monthly journal established in 2001 focused on genitourinary cancers. It features an international editorial board comprised of prominent thought leaders, including Editor in- Chief Dr. Oliver Sartor. It is mailed free of charge to US-based medical oncologists, urologists, radiation oncologists, hematologists and surgical oncologists. Each issue features peer-reviewed original contributions, comprehensive reviews and case reports, commentaries, and current trial reports. Also included are brief editorials of current news and the latest topics concerning genitourinary cancer issues relevant to clinicians.

Editor in Chief: Oliver Sartor, MD, <br/>Deputy Editor: Nicholas Vogelzang, MD
2023
Clinical Genitourinary Cancer
Global Print Circulation
10,006
Avg. Global Monthly Visits
3,983
Avg. Global Monthly Unique Visitors
3,192
Avg. Global Monthly Page Views
10,540
Avg. Global eTOC Distribution
13,321
Circulation updated on August 18th, 2022, based on 12-month monthly average July 2021-June 2022. eTOC Metrics: 6 Month Average of eTOC sends - Nov 2022 to April 2023

Rate Card

Find the best value for your advertising dollars

Download

Visit Journal Website

Find out more directly from the source

Visit

View All Journal Metrics

Detailed insights into the reach and penetration of this journal

Visit

Contacts

Display Advertising

Recruitment Advertising

Looking for more information?

If you would like to be contacted by one of our advertising experts, please complete our Request Contact form and we will get right back to you.